What is acoramidis hydrochloride?
Acoramidis hydrochloride is the hydrochloride salt form of acoramidis, a drug candidate being studied for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM). [1]
What condition is it intended to treat?
It is intended to treat transthyretin amyloid cardiomyopathy, a disease in which misfolded transthyretin proteins form amyloid deposits and damage the heart. [1]
How is it being studied (and what does that imply for availability)?
Because acoramidis is described as a drug candidate in the provided information, it is not described here as an already established, approved medicine for general use. That means availability and dosing depend on regulatory status and clinical trial outcomes, which are not detailed in the provided material. [1]
Why is it formulated as “hydrochloride”?
Hydrochloride salt forms are commonly used to improve drug stability and facilitate manufacturing and consistent dosing. The provided information identifies acoramidis hydrochloride as the salt form, but does not give specific formulation or pharmacokinetic details. [1]
What should I look for next if I’m researching it?
If you’re trying to find practical details (approved indications, dose, side effects, drug interactions, or who makes it), the next step is to check the regulatory/labeling status for acoramidis and its trial publications, since those points are not included in the information provided here. [1]
Sources:
[1] https://go.drugbank.com/drugs/DB16161